Gene Query: AEBP2

Dataset Description Geneva Score
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 22.08
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 20.37
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 17.95
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 17.95
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 16.82
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 16.65
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 16.65
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 15.82
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 15.44
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 14.31
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 14.15
R430: A potent inbibitor of DNA and RNA viruses 13.86
Effect of drugs on transcriptomic profiles 13.79
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 13.68
Triple vectors expand AAV transfer capacity in the retina 13.22
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 13.14
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 12.77
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 12.67
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 12.17
mRNA expression profile of Lymphocytes 12.11
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 12.05
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 12.05
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 11.79
DART-seq: an antibody-free method for global m6A detection 11.77
Seletive inhibition of CDK9 in DLBCL cell lines 11.5
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 11.25
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 10.84
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 10.72
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 10.29
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 10.22
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 9.79
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 9.77
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 9.63
Effect of PBK knockdown on C4-2 cell transcriptome 9.04
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 8.98
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 8.98
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 8.97
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 8.89
RNA expression analysis upon JMJD1C depletion 8.86
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 8.86
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 8.69
Global Mapping of Human RNA-RNA Interactions 8.61
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 8.6
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 8.48
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 8.39
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 8.34
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 8.33
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 8.16
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 8.08
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 7.85
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 7.82
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 7.72
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 7.59
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 7.57
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 7.47
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 7.38
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 7.38
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 7.33
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 7.32
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 7.31
Gene expression profiling of leukemia cells following asparagine depletion 7.28
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 7.23
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 7.22
Gene expressions of H9s in different culture systems 7.16
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 7.16
Integrating single-cell transcriptomic data across different conditions, technologies, and species 7.13
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 7.03
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 6.99
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 6.97
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 6.94
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 6.94
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 6.91
Human cell line and subcutaneous tumor 6.91
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 6.88
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 6.88
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 6.85
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 6.76
Transcriptome analysis in Neobractatin treated cells 6.72
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 6.7
RNA-Seq from early time points in the kidney differentiation protocol 6.62
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 6.61
The evolution of N6-methyladenosine in primates 6.56
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 6.5
The Genetic Landscape of Diamond-Blackfan Anemia 6.47
Tracking of dCas9-methyltransferase footprints 6.46
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 6.39
Illumina Total RNA-seq in HeLa 6.38
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 6.36
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 6.36
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 6.32
Transcriptome analysis of virus infected tissues 6.21
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 6.19
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 6.19
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 6.17
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 6.11
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 6.1
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 6.09
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 6.04
CROP-Seq in Primary Human T Cells 6.03
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 5.98
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 5.96
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 5.96
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 5.93
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 5.93
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 5.91
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 5.91
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 5.85
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 5.85
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 5.85
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 5.84
Gene expression analysis of the impact of TDP-43 knockout in human cells. 5.8
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 5.75
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 5.75
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 5.72
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 5.71
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 5.57
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 5.57
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 5.55
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 5.54
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 5.52
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 5.52
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 5.51
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 5.45
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 5.44
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 5.42
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 5.41
Identification of renal resident macrophages across species [C1] 5.36
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 5.36
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 5.35
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 5.31
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 5.28
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 5.25
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 5.18
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 5.17
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 5.15
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 5.15
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 5.14
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 5.13
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 5.13
Single-Cell Genotyping of Transcriptomes 5.12
RNA-seq of Single-Cell Genotyping of Transcriptomes 5.12
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 5.1
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 5.06
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 5.05
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 5.05
Effect of Influenza virus infection on lncRNA expression in A549 cells 5.05
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 5.01
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 4.98
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 4.97
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 4.96
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 4.96
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 4.95
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 4.95
The interplay between SOX4 and SMAD3 in the context of breast cancer 4.91
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 4.87
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 4.82
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 4.82
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 4.81
Glioblastoma stem cells infected by ZIKA virus 4.8
Effect of PRDM11 depletion in U2932 cells 4.76
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 4.76
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 4.75
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 4.72
Gene expression profiling in metabolically heterogeneous human lung tumors 4.71
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 4.69
A role for ZNF598 in post-transcriptional gene regulation 4.68
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 4.66
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 4.65
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 4.58
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 4.56
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 4.56
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 4.55
RNA-seq of stable and unstable section of human atherosclerotic plaques 4.54
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 4.52
Hypoxic transcriptome of SQ20B human head and neck cancer cells 4.49
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 4.48
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 4.48
Epigenetic reprogramming of melanoma cells by vitamin C treatment 4.39
TCF7L1 knockdown in pancreatic cancer 4.39
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 4.38
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 4.38
Role of microRNAs in the interaction between Salmonella and the host cell 4.35
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 4.34
Identification of HOXB13 target genes responsive to BET inhibitors 4.3
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 4.29
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 4.28
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 4.27
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 4.26
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 4.26
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 4.26
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 4.25
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 4.24
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 4.24
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 4.21
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 4.19
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 4.14
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 4.09
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 4.08
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 4.08
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 4.08
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 4.06
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 4.06
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 4.05
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 4.04
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 4.03
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 4.02
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 4.02
The human blood-nerve barrier transcriptome 3.98
Biological effect of chronic mistranslation in mammalian cells 3.98
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 3.96
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 3.96
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 3.95
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 3.95
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 3.95
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 3.94
RNAseq analysis of ESRP regulated splicing events in prostate cancer 3.92
Cerebellar differentiation in Ataxia-Telangiectasia 3.92
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 3.9
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 3.89
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 3.89
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 3.87
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 3.86
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 3.86
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 3.84
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 3.83
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 3.83
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 3.83
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 3.81
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 3.81
An optimization system for isolating and sequencing of single human colon cancer cells 3.8
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 3.8
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 3.8
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 3.77
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 3.76
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 3.7
Tracing Enhancer Networks using Epigenetic Traits (TENET) 3.69
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 3.68
Genes significantly down or Up-regulated upon RNF219 knockdown 3.68
Effect of BMP inhibition or stimulation of primary human keratinocytes 3.67
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 3.67
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 3.64
AMPK signaling for naïve pluripotency [Hs] 3.61
AMPK signaling for naïve pluripotency 3.61
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 3.59
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 3.58
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 3.57
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 3.57
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 3.55
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 3.55
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 3.55
High-throughput sequencing of PROMPT-enriched samples. 3.54
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 3.49
Peptidomimetic blockade of MYB in acute myeloid leukemia 3.48
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 3.48
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 3.47
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 3.43
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 3.41
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 3.39
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 3.37
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 3.36
IMP3 regulated gene expression in breast cancer cells 3.36
In vitro modeling of human germ cell development using pluripotent stem cells 3.35
RNA-seq of cancer cell lines treated with T-025 3.32
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 3.32
RNA seq comparison between scrambled and shGRP78 cells 3.31
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 3.31
The effect of Abl kinases on non-small cell carcinoma global transcriptome 3.31
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 3.29
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 3.29
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 3.27
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 3.21
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 3.19
Identification of global XBP1s target gene expression in human prostate cancer cells 3.17
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 3.15
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 3.14
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 3.14
m6A-dependent regulation of messenger RNA stability 3.11
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 3.11
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 3.07
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 3.06
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 3.06
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 3.01
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 3.0
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 2.98
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 2.97
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 2.95
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 2.95
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 2.93
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 2.92
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 2.91
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 2.86
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 2.82
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 2.82
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 2.79
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 2.79
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 2.75
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 2.75
Microprocessor mediates transcription termination in long noncoding microRNA genes 2.73
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 2.62
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 2.61
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 2.61
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 2.61
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 2.57
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 2.56
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 2.56
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 2.52
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 2.52
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 2.51
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 2.51
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 2.51
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 2.48
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 2.45
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 2.44
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 2.44
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 2.43
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 2.41
mRNA recovered upon RNF219 IP. [RNA-IP] 2.39
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 2.37
Capturing the Interactome of Newly Transcribed RNA 2.35
Capturing the Interactome of Newly Transcribed RNA (RICK) 2.35
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 2.32
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 2.31
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 2.31
The effect of insulin on mRNA transcription of human pluripotent stem cells 2.28
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 2.26
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 2.24
Gene expression signatures of innate lymphoid cells from human blood 2.24
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 2.18
hnRNP C is a key regulator of protein synthesis in mitosis 2.16
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 2.12
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 2.12
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 2.11
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 2.11
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 2.09
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 2.09
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 2.09
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 2.07
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.07
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 2.06
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 2.02
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 2.0
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 1.99
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 1.98
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 1.98
Identification of renal resident macrophages across species 1.97
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 1.97
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 1.97
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 1.95
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 1.95
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.94
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 1.92
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 1.92
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 1.91
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 1.87
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 1.86
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 1.83
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 1.82
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 1.82
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 1.82
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 1.76
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 1.72
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 1.7
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 1.64
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 1.59
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 1.56
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 1.56
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 1.55
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 1.55
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 1.52
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 1.51
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.47
Transcriptome-wide response to synthetic chromatin protein PcTF 1.46
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 1.46
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 1.46
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 1.42
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 1.42
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 1.4
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.39
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 1.38
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 1.35
Human HAP1 cells before and after nutrient deprivation 1.35
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.33
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 1.29
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 1.25
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 1.21
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 1.2
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 1.15
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 1.15
RNA-seq data 1.13
Transcriptome profiling of A2M treated A549 Cell Line Samples 1.12
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 1.09
Function and hormonal regulation of GATA3 in human first trimester placentation 1.08
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 1.08
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  1.07
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 1.07
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 1.06
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.05
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.04
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 1.03
Hepatosplenic T cell lymphoma 1.03
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 1.03
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 1.02
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 1.01
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 1.01
Regulating Interleukin-2 activity with engineered receptor signaling clamps 1.01
Functional significance of the HIV-1 Tat signature amino acid residues 0.99
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 0.98
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.97
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.96
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.95
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.95
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 0.94
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.94
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.89
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.87
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.87
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 0.87
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.86
The cohesin release factor WAPL restricts chromatin loop extension. 0.84
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 0.84
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 0.81
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 0.8
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 0.8
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 0.78
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 0.78
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.78
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.77
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 0.73
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 0.69
Role of FGFR1 in neuronal devlopment 0.68
High-resolution comparative analysis of great ape genomes 0.66
CUREfast: Accelerating research with families 0.64
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 0.63
RNA-seq analysis of control and Myc-induced U2OS cells 0.62
Expression patterns in chronic thromboembolic pulmonary hypertension 0.6
Global transcriptome analysis of WT versus HEB-/- hESCs 0.59
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.58
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 0.54
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 0.54
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 0.53
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 0.51
Genome-wide discovery of human splicing branchpoints [RNAse] 0.5
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 0.5
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 0.5
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 0.49
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.48
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 0.48
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 0.47
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 0.47
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 0.47
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.46
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 0.46
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 0.46
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 0.44
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 0.44
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 0.43
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 0.39
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 0.38
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 0.38
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 0.38
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 0.37
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 0.37
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 0.36
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 0.36
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.35
Transcriptome-wide modulation of splicing by the exon junction complex 0.34
The role of m6A/m-RNA methylation in stress response regulation 0.32
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.32
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 0.32
Enhancer activation during EGF response 0.3
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.3
Oncogenic roles of ARID5B in T-ALL 0.3
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.29
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 0.27
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 0.26
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.25
Modulation of nonsense-mediated decay by rapamycin 0.24
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 0.23
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 0.2
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 0.2
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.18
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.17
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.15
Transcriptome of human ILC2s; primary vs IL-1b-primed 0.15
Direct Isolation and Characterization of Human Nephron Progenitors. 0.12
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.11
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.1
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 0.1
ADAR1-editing of cellular and measles virus-derived duplex RNA 0.1
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.09
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.08
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 0.08
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.06
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 0.06
Epigenomic conservation of transposable element silencing 0.06
Epigenomic conservation of transposable element silencing [RNA-seq] 0.06
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 0.04
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 0.03
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 0.02
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation